XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.19.2

Earnings per Common Share | 6 Months Ended
--- | ---
Jun. 30, 2019
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 111.0 |  |  | $ | 113.0 |  |  | $ | 236.7 |  |  | $ | 218.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (19.7 | ) |  | (21.4 | ) |  | (42.6 | ) |  | (42.8 | )
Less: Income allocated to participating securities | (0.3 | ) |  | (0.3 | ) |  | (0.7 | ) |  | (0.6 | )
Income from continuing operations attributable to Encompass Health common shareholders | 91.0 |  |  | 91.3 |  |  | 193.4 |  |  | 175.3 |
(Loss) income from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.1 | ) |  | 0.2 |  |  | (0.6 | ) |  | (0.3 | )
Net income attributable to Encompass Health common shareholders | $ | 90.9 |  |  | $ | 91.5 |  |  | $ | 192.8 |  |  | $ | 175.0 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 98.0 |  |  | 97.9 |  |  | 98.2 |  |  | 97.9 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.93 |  |  | $ | 0.93 |  |  | $ | 1.97 |  |  | $ | 1.79 |
Discontinued operations | — |  |  | — |  |  | (0.01 | ) |  | — |
Net income | $ | 0.93 |  |  | $ | 0.93 |  |  | $ | 1.96 |  |  | $ | 1.79 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 111.0 |  |  | $ | 113.0 |  |  | $ | 236.7 |  |  | $ | 218.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (19.7 | ) |  | (21.4 | ) |  | (42.6 | ) |  | (42.8 | )
Income from continuing operations attributable to Encompass Health common shareholders | 91.3 |  |  | 91.6 |  |  | 194.1 |  |  | 175.9 |
(Loss) income from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.1 | ) |  | 0.2 |  |  | (0.6 | ) |  | (0.3 | )
Net income attributable to Encompass Health common shareholders | $ | 91.2 |  |  | $ | 91.8 |  |  | $ | 193.5 |  |  | $ | 175.6 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 99.3 |  |  | 99.6 |  |  | 99.5 |  |  | 99.6 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.92 |  |  | $ | 0.92 |  |  | $ | 1.95 |  |  | $ | 1.76 |
Discontinued operations | — |  |  | — |  |  | (0.01 | ) |  | — |
Net income | $ | 0.92 |  |  | $ | 0.92 |  |  | $ | 1.94 |  |  | $ | 1.76 |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Basic weighted average common shares outstanding | 98.0 |  |  | 97.9 |  |  | 98.2 |  |  | 97.9 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.3 |  |  | 1.7 |  |  | 1.3 |  |  | 1.7 |
Diluted weighted average common shares outstanding | 99.3 |  |  | 99.6 |  |  | 99.5 |  |  | 99.6 |
In October 2018, February 2019, and May 2019, our board of directors declared cash dividends of $0.27 per share that were paid in January 2019, April 2019, and July 2019, respectively. On July 23, 2019, our board of directors approved an increase in our quarterly dividend and declared a cash dividend of $0.28 per share, payable on October 15, 2019 to stockholders of record on October 1, 2019. As of June 30, 2019 and December 31, 2018, accrued common stock dividends of $27.8 million and $28.4 million, respectively, were included in Accrued expenses and other current liabilities in our condensed consolidated balance sheets. Future dividend payments are subject to declaration by our board of directors. See Note 16, Earnings per Common Share, to the consolidated financial statements accompanying the 2018 Form 10‑K for additional information related to our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration